Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Individualized Decoction (Shanghai University of Traditional Chinese Medicine) is a personalized Traditional Chinese Medicine (TCM) herbal therapy developed for the treatment of stable bronchiectasis. The treatment is based on the Bronchiectasis Stabilization Decoction (BSD), which serves as a core formula containing herbs such as Rhizoma Fagopyri Cymosi, Radix Lithospermi, Radix Ophiopogonis, Poria cocos, Radix Astragali, Rhizoma Bletillae, Platycodon grandiflorum, and Semen Coicis. This base formula is then modified according to the patient's specific TCM syndrome (syndrome differentiation); for instance, adding Radix Scutellariae for phlegm-heat or Adenophora Root for qi and yin deficiency. The therapy aims to strengthen body resistance and remove phlegm, and it has been evaluated in N-of-1 randomized, double-blind, crossover trials to assess its efficacy in symptom management and its impact on the quality of life in bronchiectasis patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Individualized Decoction.